Quantifying Heterogeneous Malaria Exposure and Clinical Protection in a Cohort of Ugandan Children

Journal of Infectious Diseases

Volumn 214, Issue 7, 2016, Pages 1072-1080

  Rodriguez Barraquer, Isabel ^a   Arinaitwe, Emmanuel ^d   Jagannathan, Prasanna ^b   Boyle, Michelle J ^b,g   Tappero, Jordan ^c   Muhindo, Mary ^e   Kamya, Moses R ^f   Dorsey, Grant ^b   Drakeley, Chris ^h   Ssewanyana, Isaac ^e   Smith, David L ^h   Greenhouse, Bryan ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Institute for Heath Metrics and Evaluation   (United States)

^e INFECTIOUS DISEASES RESEARCH COLLABORATION   (Uganda)

^f MAKERERE UNIVERSITY COLLEGE OF HEALTH SCIENCES   (Uganda)

^g BURNET INSTITUTE   (Australia)

^h LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

epidemiology; heterogeneity in transmission; immunity; malaria

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL;

CHILD; CHILD HEALTH; COHORT ANALYSIS; CONFERENCE PAPER; DISEASE ASSOCIATION; DRUG EFFECT; EXPOSURE; FEMALE; FOLLOW UP; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALARIA; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME; UGANDAN; IMMUNOLOGY; LONGITUDINAL STUDY; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; RISK FACTOR; UGANDA;

CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALARIA, FALCIPARUM; MALE; PLASMODIUM FALCIPARUM; RISK ASSESSMENT; RISK FACTORS; UGANDA;

EID: 84994168607     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw301     Document Type: Conference Paper

References (42)

1. World Health Organization (WHO).World malaria report 2014. Geneva, Switzerland: WHO, 2014.
2. Naghavi M, Wang H, Lozano R, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385:117-71.
3. Kilama M, Smith DL, Hutchinson R, et al. Estimating the annual entomological inoculation rate for Plasmodium falciparum transmitted by Anopheles gambiae s.l. using three sampling methods in three sites in Uganda. Malar J 2014; 13:111.
4. Gething PW, Patil AP, Smith DL, et al. A new world malaria map: Plasmodium falciparumendemicity in 2010. Malar J 2011; 10:378.
5. Okello PE, Van BortelW, Byaruhanga AM, et al. Variation in malaria transmission intensity in seven sites throughout Uganda. Am J Trop Med Hyg 2006; 75:219-25.
6. Griffin JT, Hollingsworth TD, Reyburn H, Drakeley CJ, Riley EM, Ghani AC. Gradual acquisition of immunity to severe malaria with increasing exposure. Proc R Soc Lond [Biol] 2015; 282:20142657.
7. Reyburn H, Mbatia R, Drakeley C, et al. Association of transmission intensity and age with clinical manifestations and case fatality of severe Plasmodium falciparum malaria. JAMA 2005; 293:1461-70.
8. Okiro EA, Al-Taiar A, Reyburn H, Idro R, Berkley JA, Snow RW. Age patterns of severe paediatric malaria and their relationship to Plasmodium falciparum transmission intensity. Malar J 2009; 8:4.
9. Carneiro I, Roca-Feltrer A, Griffin JT, et al. Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS ONE 2010; 5:e8988.
10. Idro R, Aloyo J, Mayende L, Bitarakwate E, John CC, Kivumbi GW. Severe malaria in children in areas with low, moderate and high transmission intensity in Uganda. Trop Med Int Health 2006; 11:115-24.
11. Roca-Feltrer A, Carneiro I, Smith L, Schellenberg JR, Greenwood B, Schellenberg D. The age patterns of severe malaria syndromes in sub-Saharan Africa across a range of transmission intensities and seasonality settings. Malar J 2010; 9:282.
12. Tran TM, Li S, Doumbo S, et al. An intensive longitudinal cohort study of Malian children and adults reveals no evidence of acquired immunity to Plasmodium falciparum infection. Clin Infect Dis 2013; 57:40-7.
13. Smith DL, Guerra CA, Snow RW, Hay SI. Standardizing estimates of the Plasmodium falciparumparasite rate. Malar J 2007; 6:131.
14. Bejon P,Williams TN, Nyundo C, et al. A micro-epidemiological analysis of febrile malaria in Coastal Kenya showing hotspots within hotspots. Elife 2014; 3:e02130.
15. Smith DL, Dushoff J, Snow RW, Hay SI. The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature 2005; 438:492-5.
16. Clark TD, Greenhouse B, Njama-Meya D, et al. Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. J Infect Dis 2008; 198:393-400.
17. Kreuels B, Kobbe R, Adjei S, et al. Spatial variation of malaria incidence in young children from a geographically homogeneous area with high endemicity. J Infect Dis 2008; 197:85-93.
18. Oesterholt MJAM, Bousema JT,MwerindeOK, et al. Spatial and temporal variation in malaria transmission in a lowendemicity area in northernTanzania.Malar J 2006; 5:98.
19. Jagannathan P, Eccles-James I, Bowen K, et al. IFNγ/IL-10 co-producing cells dominate the CD4 response to malaria in highly exposed children. PLoS Pathog 2014; 10:e1003864.
20. Greenhouse B, Ho B, Hubbard A, et al. Antibodies to Plasmodium falciparum antigens predict a higher risk of malaria but protection from symptoms once parasitemic. J Infect Dis 2011; 204:19-26.
21. Helb DA, Tetteh KKA, Felgner PL, et al. Novel serologic biomarkers provide accurate estimates of recent Plasmodium falciparum exposure for individuals and communities. Proc Natl Acad Sci U S A 2015; 112:E4438-47.
22. Filipe JA, Riley EM, Drakeley CJ, Sutherland CJ, Ghani AC. Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model. PLoS Comput Biol 2007; 3:e255.
23. Smith T, Ross A, Maire N, Rogier C, Trape JF, Molineaux L. An epidemiologic model of the incidence of acute illness in Plasmodium falciparum malaria. Am J Trop Med Hyg 2006; 75(2 suppl):56-62.
24. Cameron E, Battle KE, Bhatt S, et al. Defining the relationship between infection prevalence and clinical incidence of Plasmodium falciparum malaria. Nat Commun 2015; 6:8170.
25. Hviid L. Clinical disease, immunity and protection against Plasmodium falciparum malaria in populations living in endemic areas. Expert RevMolMed 1998; 1998:1-10.
26. Sandison TG, Homsy J, Arinaitwe E, et al. Protective efficacy of co-trimoxazole prophylaxis against malaria in HIV exposed children in rural Uganda: a randomised clinical trial. BMJ 2011; 342:d1617.
27. Jagannathan P, Muhindo MK, Kakuru A, et al. Increasing incidence of malaria in children despite insecticide-treated bed nets and prompt anti-malarial therapy in Tororo, Uganda. Malar J 2012; 11:435.
28. Arinaitwe E, Sandison TG, Wanzira H, et al. Artemether-lumefantrine versus dihydroartemisinin-piperaquine for falciparum malaria: a longitudinal, randomized trial in Young Ugandan Children. Clin Infect Dis 2009; 49: 1629-37.
29. Stan development Team. Stan: A C++ Library for Probability and Sampling, Version 2.5.0. [Internet]. http://mc-stan.org/.
30. R: A language and environment for statistical computing. RFoundation for Statistical Computing. 2nd ed. Vienna, Austria. http://www.R-project.org/.
31. Gelman A, Rubin DB. Inference from iterative simulation using multiple sequences. Stat Sci 1992; 7:457-72.
32. Spiegelhalter DJ, Best NG, Carlin BP, Van Der Linde A. Bayesian measures of model complexity and fit. J R Stat Soc Ser A 2002; 64:583-639.
33. Wanzira H, Kakuru A, Arinaitwe E, et al. Longitudinal outcomes in a cohort of Ugandan children randomized to artemether-lumefantrine versus dihydroartemisinin-piperaquine for the treatment of malaria. Clin Infect Dis 2014; 59: 509-16.
34. Port GR, Boreham P, Bryan JH. The relationship of host size to feeding by mosquitoes of the Anopheles gambiae Giles complex (Diptera: Culicidae). Bull Entomol Res 1980; 70:133-44.
35. Struik SS, Riley EM. Does malaria suffer from lack of memory? Immunol Rev 2004; 201:268-90.
36. Rogier C, Commenges D, Trape J. Evidence for an age-dependent pyrogenic threshold of Plasmodium falciparum parasitemia in highly endemic populations. Am J Trop Med Hyg 1996; 54:613-9.
37. Bødker R, Msangeni HA, KisinzaW, Lindsay SW. Relationship between the intensity of exposure to malaria parasites and infection in the Usambara Mountains, Tanzania. Am J Trop Med Hyg 2006; 74:716-23.
38. Baird JK. Host age as a determinant of naturally acquired immunity to Plasmodium falciparum. Parasitol Today (Regul Ed) 1995; 11:105-11.
39. Aron JL. Mathematical modelling of immunity to malaria. Math Biosci 1988; 90:385-96.
40. Maire N, Smith T, Ross A, Owusu-Agyei S, Dietz K, Molineaux L. A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. Am J Trop Med Hyg 2006; 75(2 suppl):19-31.
41. Smith T, Killeen GF, Maire N, et al. Mathematical modeling of the impact of malaria vaccines on the clinical epidemiology and natural history of Plasmodium falciparum malaria: Overview. Am J Trop Med Hyg 2006; 75(2 suppl):1-10.
42. White NJ. Intermittent presumptive treatment for malaria. PLoS Med 2005; 2:e3.